The following data is part of a premarket notification filed by Randox Laboratories, Ltd. with the FDA for Randox Microalbumin.
Device ID | K002674 |
510k Number | K002674 |
Device Name: | RANDOX MICROALBUMIN |
Classification | Albumin, Fitc, Antigen, Antiserum, Control |
Applicant | RANDOX LABORATORIES, LTD. 55 DIAMOND RD. Crumlin, Co. Antrim, IE Bt29 4qy |
Contact | Pauline Armstrong |
Correspondent | Pauline Armstrong RANDOX LABORATORIES, LTD. 55 DIAMOND RD. Crumlin, Co. Antrim, IE Bt29 4qy |
Product Code | DDZ |
CFR Regulation Number | 866.5040 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2000-08-28 |
Decision Date | 2000-10-05 |
Device Identifier | submissionNumber | Supplement |
---|---|---|
05055273209259 | K002674 | 000 |
05055273204568 | K002674 | 000 |
05055273204551 | K002674 | 000 |
05055273204544 | K002674 | 000 |
05055273204537 | K002674 | 000 |